Recruiting NA INTERVENTIONAL 2-arm NCT04908644

MS-20 on Patients With Ulcerative Colitis(UC)

Study to Evaluate Efficacy and Safety of MS 20 on Patients With Ulcerative Colitis

Sponsor: Microbio Co Ltd

Interventions MS-20 oral solution Placebo

Updated 4 times since 2021 Last updated: Jun 5, 2024 Started: Aug 18, 2021 Primary completion: Nov 30, 2024 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04908644, this NA trial focuses on Ulcerative Colitis and remains actively recruiting participants. Sponsored by Microbio Co Ltd, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jul 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Jul 2022 [monthly]

Not Yet Recruiting NA

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Microbio Co Ltd
National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan